B-Cell Lymphomas Global Clinical Trials Review, H1, 2012

Summary

companys clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, H1, 2012 provides data on the B-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on B-Cell Lymphomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating B-Cell Lymphomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by companys team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables 5
List of Figures 7
Introduction 8
B-Cell Lymphomas 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of B-Cell Lymphomas 25
Subjects Recruited Over a Period of Time 31
Prominent Sponsors 32
Top Companies Participating in B-Cell Lymphomas Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
F. Hoffmann-La Roche Ltd. 37
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
GlaxoSmithKline plc 40
Clinical Trial Overview of GlaxoSmithKline plc 40
Celgene Corporation 41
Clinical Trial Overview of Celgene Corporation 41
Eli Lilly and Company 42
Clinical Trial Overview of Eli Lilly and Company 42
Millennium Pharmaceuticals, Inc. 43
Clinical Trial Overview of Millennium Pharmaceuticals, Inc. 43
Takeda Pharmaceutical Company Limited 44
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 44
Novartis AG 45
Clinical Trial Overview of Novartis AG 45
Sanofi 46
Clinical Trial Overview of Sanofi 46
Pharmacyclics, Inc. 47
Clinical Trial Overview of Pharmacyclics, Inc. 47
SymBio Pharmaceuticals Limited 48
Clinical Trial Overview of SymBio Pharmaceuticals Limited 48
Biogen Idec Inc. 49
Clinical Trial Overview of Biogen Idec Inc. 49
Merck & Co., Inc. 50
Clinical Trial Overview of Merck & Co., Inc. 50
Cephalon, Inc. 51
Clinical Trial Overview of Cephalon, Inc. 51
Cell Therapeutics, Inc. 52
Clinical Trial Overview of Cell Therapeutics, Inc. 52
Seattle Genetics, Inc. 53
Clinical Trial Overview of Seattle Genetics, Inc. 53
MedImmune, LLC 54
Clinical Trial Overview of MedImmune, LLC 54
AstraZeneca PLC 55
Clinical Trial Overview of AstraZeneca PLC 55
Amgen Inc. 56
Clinical Trial Overview of Amgen Inc. 56
IMMUNOMEDICS, INC 57
Clinical Trial Overview of IMMUNOMEDICS, INC 57
Clinical Trial Overview of Top Universities / Institutes / Hospitals 58
Fred Hutchinson Cancer Research Center 58
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 58
The University of Texas M. D. Anderson Cancer Center 62
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 62
Dana-Farber Cancer Institute 64
Clinical Trial Overview of Dana-Farber Cancer Institute 64
Groupe dEtudes de Lymphomes de LAdulte 66
Clinical Trial Overview of Groupe dEtudes de Lymphomes de LAdulte 66
Southwest Oncology Group 68
Clinical Trial Overview of Southwest Oncology Group 68
Mayo Clinic 70
Clinical Trial Overview of Mayo Clinic 70
Duke University 71
Clinical Trial Overview of Duke University 71
City of Hope National Medical Center 72
Clinical Trial Overview of City of Hope National Medical Center 72
Weill Cornell Medical College 73
Clinical Trial Overview of Weill Cornell Medical College 73
Memorial Sloan Kettering Cancer Center 74
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 74
Massachusetts General Hospital 75
Clinical Trial Overview of Massachusetts General Hospital 75
Groupe d Etude des Lymphomes de l Adulte 76
Clinical Trial Overview of Groupe d Etude des Lymphomes de l Adulte 76
UCLAs Jonsson Comprehensive Cancer Center 77
Clinical Trial Overview of UCLAs Jonsson Comprehensive Cancer Center 77
Sarah Cannon Research Institute 78
Clinical Trial Overview of Sarah Cannon Research Institute 78
Groupe Ouest Est dEtude des Leucemies et Autres Maladies du Sang GOELAMS 79
Clinical Trial Overview of Groupe Ouest Est dEtude des Leucemies et Autres Maladies du Sang GOELAMS 79
Swiss Group for Clinical Cancer Research 80
Clinical Trial Overview of Swiss Group for Clinical Cancer Research 80
University of Wisconsin Madison 81
Clinical Trial Overview of University of Wisconsin Madison 81
Stanford University 82
Clinical Trial Overview of Stanford University 82
H. Lee Moffitt Cancer Center & Research Institute 83
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 83
Case Comprehensive Cancer Center 84
Clinical Trial Overview of Case Comprehensive Cancer Center 84
Five Key Clinical Profiles 85
Appendix 112
Abbreviations 112
Definitions 112
Research Methodology 113
Secondary Research 113
About company 114
Contact Us 114
Disclaimer 114
Source 115

List of Tables

B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
B-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
B-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
B-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
B-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 15
B-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16
B-Cell Lymphomas Therapeutics Clinical Trials, BRIC Countries, 2012* 17
B-Cell Lymphomas Therapeutics Clinical Trials, G7 Countries, 2012* 18
B-Cell Lymphomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
B-Cell Lymphomas Therapeutics Clinical Trials, E7 Countries, 2012* 20
B-Cell Lymphomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
B-Cell Lymphomas Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
B-Cell Lymphomas Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
B-Cell Lymphomas Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 31
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 33
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 35
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 37
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 39
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 40
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 41
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 42
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Millennium Pharmaceuticals, Inc., 2012* 43
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012* 44
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 45
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 46
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012* 47
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by SymBio Pharmaceuticals Limited, 2012* 48
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2012* 49
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 50
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2012* 51
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Therapeutics, Inc., 2012* 52
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2012* 53
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2012* 54
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 55
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 56
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by IMMUNOMEDICS, INC, 2012* 57
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 58
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 62
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 64
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe dEtudes de Lymphomes de LAdulte, 2012* 66
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012* 68
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 70
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 71
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012* 72
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012* 73
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 74
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 75
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d Etude des Lymphomes de l Adulte, 2012* 76
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLAs Jonsson Comprehensive Cancer Center, 2012* 77
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012* 78
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe Ouest Est dEtude des Leucemies et Autres Maladies du Sang GOELAMS, 2012* 79
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Swiss Group for Clinical Cancer Research, 2012* 80
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012* 81
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 82
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012* 83
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 84

List of Figures

B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
B-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
B-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
B-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
B-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 15
B-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16
B-Cell Lymphomas Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
B-Cell Lymphomas Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
B-Cell Lymphomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
B-Cell Lymphomas Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
B-Cell Lymphomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 31
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 32
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 34
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36
company Methodology 113